Abnormal TRPM7 activity has been implicated in hypertension, cardiac fibrosis, inflammation and atrial fibrillation (AF) (16–19), with TRPM7 downregulation promoting cardiovascular injury. This evidence concerns the gene TRPM7 and Hypertension.